
Marathon Running with Type 1 Diabetes: New Study Shows It's Possible with the Right Tools
A small study of runners with type 1 diabetes completing a marathon found that continuous glucose monitoring and adjusted insulin management allowed them to finish safely with times comparable to runners without diabetes.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- People with type 1 diabetes completed a full 42-km marathon using continuous glucose monitoring (CGM) devices to track blood sugar in real time.
- Runners with diabetes finished with comparable times to non-diabetic runners, suggesting that diabetes does not prevent competitive marathon performance.
- Success required planning: reduced insulin doses before the race and careful carbohydrate intake during running.
- This small study adds evidence that endurance exercise like marathons can be safe for people with type 1 diabetes when properly managed.
What the Research Looked At
A research team from Poznan University of Medical Sciences and Raszeja City Hospital in Poland studied 20 amateur runners during the 2025 Poznań Marathon—a standard 42-kilometer (26-mile) race. Ten runners had type 1 diabetes with at least one year of diabetes history, and ten runners did not have diabetes.
The researchers wanted to understand what happens to blood sugar levels during a real marathon. They tracked glucose patterns, how much carbohydrate runners ate, and how accurately CGM devices measured glucose during the race. Until now, there has been limited real-world evidence on these questions during prolonged endurance exercise.
How Runners with Diabetes Prepared
Runners with type 1 diabetes made specific adjustments to manage their insulin and blood sugar during the race. They aimed for a pre-race glucose target of 140–200 mg/dL to have a safety buffer before starting.
On race day, insulin doses were reduced: runners using multiple daily injections cut their basal insulin by 25%, while those on non-hybrid insulin pumps reduced it by 50%. Runners using hybrid closed-loop systems—pumps that automatically adjust insulin—set a target glucose of 150 mg/dL and let the system make adjustments during the race.
The Results
All runners with type 1 diabetes completed the marathon safely. Their finishing times were comparable to the finishing times of runners without diabetes, suggesting that having type 1 diabetes did not slow them down when the race was properly managed.
The results suggest that with continuous glucose monitoring and thoughtful adjustments to insulin and carbohydrate intake, marathons can be completed safely by people with type 1 diabetes.
What This Means
This research was presented at the Annual Meeting of the European Association for the Study of Diabetes in September 2026. Because it was a small study of amateur runners, the findings show what's possible but do not prove that all people with type 1 diabetes can safely run marathons without individual preparation and medical guidance.
Anyone with type 1 diabetes interested in endurance exercise like marathon running should work with their healthcare team to develop a personalized plan for insulin adjustment, glucose monitoring, and carbohydrate intake.
Evidence label
Origin: medicalxpress.com (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DHow Automated Insulin Delivery Systems Work and What the Research ShowsVideo report, corroborated with 5 indexed studies
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DHow Text Messages and Digital Tools Help Young Adults Manage Type 1 Diabetes During a Challenging Life TransitionNews report, corroborated with 1 indexed study
- Living With T1DWhat Continuous Glucose Monitors Can and Can't Do for Type 1 DiabetesVideo report, corroborated with 5 indexed studies